A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to ...

Mara Sherman, PhD, was awarded the Mark Foundation 2025 Emerging Leader Award, which honored five early-career scientists dedicated to revolutionizing cancer research through innovative projects. Dr.

Although common, the cause of these hernias is unknown, and the only treatment ... Cancer Vaccine Shows Promise for Patients With Stage III and IV Kidney Cancer Feb. 5, 2025 — Researchers report ...

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

A blood-based test (Freenome) may provide a new option for colorectal cancer screening in the average-risk US population.

Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with chemoradiotherapy alone in locally advanced ESCC.